Discovery Laboratories, Inc. (NASDAQ:DSCO)

CAPS Rating: 3 out of 5

A biotechnology company, which develops its proprietary surfactant technology as Surfactant Replacement Therapies for respiratory disorders and diseases.

Recs

0
Player Avatar pchop123 (71.80) Submitted: 2/2/2012 2:26:44 PM : Outperform Start Price: $2.61 DSCO Score: -1.59

speculatiooooon

Featured Broker Partners


Advertisement